BioSpace News Archive

RELIEF THERAPEUTICS Holding AG announced that its wholly owned subsidiary, APR Applied Pharma Research SA, has launched, through its affiliates in Germany and Italy, PKU GOLIKE KRUNCH, a convenient chewable tablet for the dietary management of phenylketonuria, a rare, recessive metabolic genetic disorder affecting approximately 350,000 people globally.

Deepcell today announced the appointment of Kevin Jacobs as the Vice President of Bioinformatics.

A new study, published today in peer-review medical journal Aging, marks the first time non-pharmaceutical clinical exploration proves efficacy in reversing the main activators of Alzheimer’s disease.

Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the official launch of the FuseChoice™ Dermal Matrix line (“FuseChoice™ Derm”).

Positive results from the POSEIDON Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab), and tremelimumab, when added to platinum-based chemotherapy, demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) and progression-free survival (PFS) compared to chemotherapy alone in the 1st-line treatment of patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC).

PharmaForce International (PFI) recently completed a study that benchmarks the leading Oncology/Hematology/Immuno-Oncology sales and marketing organizations in five major European countries.

Telo Genomics will showcase the clinical utility and unique advantages of its TeloView® technology, and its potential as a transformative liquid biopsy prognostics solution for managing multiple myeloma.

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the addition of two new Air-Dryable™ Master Mixes with the launch of its Air-Dryable™ Direct DNA qPCR Stool and Air-Dryable™ Direct RNA/DNA qPCR Stool Mixes.

Tevogen Bio announced the completion of technology transfer of its investigational COVID-19 therapy TVGN-489 to BioCentriq, Tevogen’s clinical manufacturing partner, representing a major milestone in achieving commercial manufacturing readiness.

Midwest Products & Engineering (MPE-INC), a leading design and contract manufacturer of medical devices, today announced its acquisition of MindFlow Design, a Southern California leading medical product design firm offering concept through manufacture-ready product specifications with a proven three-phase proprietary design process.